August 12, 2025

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 21% Upside Potential in Non-Opioid Innovations

For investors keeping a close eye on the healthcare sector, Pacira BioSciences, Inc. (NASDAQ: PCRX) offers a compelling opportunity. With its focus on non-opioid pain management..

Enovis Corporation (ENOV) Stock Analysis: Healthcare Innovator with 85.7% Potential Upside

In the dynamic world of healthcare, Enovis Corporation (NYSE: ENOV) emerges as a compelling prospect for investors seeking exposure to the medical devices sector. With a..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 34.78% Potential Upside in Health Information Services

Certara, Inc. (NASDAQ: CERT) stands as a pivotal player in the healthcare sector, specializing in health information services that leverage technology-enabled solutions for biosimulation across drug..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unpacking a 99% Potential Upside

For investors seeking opportunities in the biotechnology sector, Travere Therapeutics, Inc. (TVTX) presents a compelling case. With a market cap of $1.54 billion, this San Diego-based..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Strong Buy Consensus Signals Potential 39% Upside

Ocular Therapeutix, Inc. (OCUL), a biopharmaceutical company headquartered in Bedford, Massachusetts, is making waves in the healthcare sector with its innovative treatments for retinal diseases and..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 54% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is a standout in the healthcare sector, particularly within the medical devices industry, boasting a market capitalization of $1.65 billion. Headquartered..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 16.23% Potential Upside in the Healthcare Sector

CONMED Corporation (CNMD), a prominent player in the healthcare sector, is drawing attention with its notable presence in the medical devices industry. Headquartered in Largo, Florida,..

HUTCHMED (HCM) Stock Analysis: A 53% Upside Potential in the Dynamic Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) presents a compelling opportunity for investors looking to tap into the dynamic healthcare sector, particularly in the specialty and generic drug..

Evotec SE (EVO) Stock Analysis: Exploring a 58% Potential Upside in the Healthcare Sector

Evotec SE (EVO), a prominent player in the drug discovery and development industry, operates in the dynamic healthcare sector, focusing on innovative solutions across a broad..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 35.75% Potential Upside for Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is gaining attention from investors due to its promising potential upside of 35.75%. Operating in..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating Potential Upside with a 14.96% Gain

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring the 127% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a pioneering entity in the healthcare sector, specifically within the medical devices industry, is drawing considerable attention from investors. Known..

Merus N.V. (MRUS) Stock Analysis: 39.94% Potential Upside in a Booming Biotechnology Sector

Merus N.V. (MRUS), headquartered in Utrecht, Netherlands, is a promising player in the biotechnology sector, specifically in the field of immuno-oncology. As a clinical-stage company, Merus..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 39.41% Potential Upside with Innovative PAH Treatments

Liquidia Corporation (NASDAQ: LQDA), a key player in the healthcare sector, specializes in the biotechnology industry with a focus on advancing treatments for pulmonary arterial hypertension..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 20.66% Potential Upside in the Biotech Sphere

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is poised to capture investor attention with its promising portfolio of medications targeting central..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating a 5.99% Upside in CNS Treatments

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, is making waves with its focus on developing and commercializing treatments for central nervous..

LifeStance Health Group, Inc. (LFST): Investor Outlook Reveals 84% Potential Upside

For investors seeking opportunities in the healthcare sector, LifeStance Health Group, Inc. (LFST) presents a compelling case with its strong growth potential and expanding reach in..

Celldex Therapeutics (CLDX) Stock Analysis: Unpacking the 192% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a cutting-edge biopharmaceutical company headquartered in Hampton, New Jersey, is capturing the attention of investors with its innovative approach to treating..

Recursion Pharmaceuticals (RXRX) Investor Outlook: Biotechnology Innovator with 22.87% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative approach to drug discovery and a notable..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a 15% Upside Amid Strong Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of innovation in the biotechnology sector, leveraging its immune medicine platform to revolutionize disease diagnosis and treatment...

Search

Funds

August 12, 2025

Search

Funds

August 12, 2025

FTSE 100

Funds